Immuneering Corporation upgraded to Strong Buy after positive phase 2a data in pancreatic cancer. Click here to find out why ...
News-Medical.Net on MSN
Genetic risk scores fail to predict survival after diagnosis
Research indicates that disease susceptibility genetics poorly predict survival, while longevity PGSs offer stronger ...
Inside the exhibition hall of Guangzhou Yundie Technology Co., Ltd. (hereinafter referred to as 'Yundie Technology'), a smart ...
In the exhibition hall of Guangzhou Cloud Butterfly Technology Co., Ltd. (hereinafter referred to as "Cloud Butterfly ...
Learn how to calculate hazard rate, its practical implications in engineering and finance, and why it's critical in ...
AI-powered analysis of routine blood tests can reveal hidden patterns that predict recovery and survival after spinal cord ...
Bizcommunity on MSN
The architect and the scaffold: A collaborative pathway to SA’s National Entrepreneurship Strategy
A strategic analysis of South Africa's National Entrepreneurship Strategy, proposing collaborative public–private ...
Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...
Avacta is slated to present the final Phase Ia dose escalation data for our lead program, faridoxorubicin. This will be at ESMO 2025 in Berlin, a little bit later next month in October of 2025. There, ...
Museums are rethinking their finances as they adapt to a new landscape of donors, digital tools, and changing values.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback